Skip to main content
Top
Published in: BMC Nephrology 1/2022

Open Access 01-12-2022 | Glomerulonephritis | Case report

A rare case of proliferative glomerulonephritis with monoclonal IgG2 kappa deposit: a case report

Authors: Daisuke Ito, Yuriko Shiozaki, Yoshitaka Shimizu, Yumiko Suzuki, Asami Takeda, Taro Misaki

Published in: BMC Nephrology | Issue 1/2022

Login to get access

Abstract

Background

Proliferative glomerulonephritis with monoclonal immunoglobulin G (IgG) deposits (PGNMID) is a rare monoclonal gammopathy of renal significance with dense deposits of monoclonal immunoglobulin.

Case presentation

We report a 78-year-old Japanese male patient with mild proteinuria and lower extremity edema. Monoclonal immunoglobulin could not be identified in his serum or urine. Although his bone marrow biopsy was negative, renal biopsy found features of membranoproliferative glomerulonephritis (MPGN) with deposition of monoclonal IgG2 kappa. Electron microscopy examination revealed non-organized electron-dense deposits in the subepithelial, and subendothelial mesangial regions. Steroid monotherapy was performed after diagnosis of PGNMID but complete remission was not achieved.

Conclusion

PGNMID with IgG3 kappa deposits is the most common in cases with the histological feature of MPGN. There are few cases of PGNMID with IgG2 kappa deposits exhibiting MPGN. This report describes a very rare case of PGNMID with the histological feature of MPGN.
Literature
1.
go back to reference Nasr SH, Satoskar A, Markowitz GS, Valeri AM, Appel GB, et al. Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol. 2009;20:2055–64.CrossRef Nasr SH, Satoskar A, Markowitz GS, Valeri AM, Appel GB, et al. Proliferative glomerulonephritis with monoclonal IgG deposits. J Am Soc Nephrol. 2009;20:2055–64.CrossRef
2.
go back to reference Kusunoki Y, Namba-Hamano T, Kakimoto T, et al. A case of proliferative glomerulonephritis with immunoglobulin A1-lambda deposits successfully treated by chemotherapy. CEN Case Rep. 2020;9:326–32.CrossRef Kusunoki Y, Namba-Hamano T, Kakimoto T, et al. A case of proliferative glomerulonephritis with immunoglobulin A1-lambda deposits successfully treated by chemotherapy. CEN Case Rep. 2020;9:326–32.CrossRef
3.
go back to reference Leung N, Bridoux F, Batuman V, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the international kidney and monoclonal Gammopathy research group. Nat Rev Nephrol. 2019;15:45–59.CrossRef Leung N, Bridoux F, Batuman V, et al. The evaluation of monoclonal gammopathy of renal significance: a consensus report of the international kidney and monoclonal Gammopathy research group. Nat Rev Nephrol. 2019;15:45–59.CrossRef
4.
go back to reference Noto R, Kamiura N, Ono Y, Tabata S, et al. Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report. BMC Nephrol. 2017;18:127.CrossRef Noto R, Kamiura N, Ono Y, Tabata S, et al. Successful treatment with bortezomib and dexamethasone for proliferative glomerulonephritis with monoclonal IgG deposits in multiple myeloma: a case report. BMC Nephrol. 2017;18:127.CrossRef
5.
go back to reference Yu XJ, Wang MJ, Yong ZH, et al. Proliferative glomerulonephritis with monoclonal IgG3λ deposits: a case report of a rare cause of monoclonal gammopathy of renal significance. Kidney Med. 2019;1:221–5.CrossRef Yu XJ, Wang MJ, Yong ZH, et al. Proliferative glomerulonephritis with monoclonal IgG3λ deposits: a case report of a rare cause of monoclonal gammopathy of renal significance. Kidney Med. 2019;1:221–5.CrossRef
6.
go back to reference Bhutani G, Nasr SH, Said SM, et al. Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin deposits. Mayo Clin Proc. 2015;90:587–96.CrossRef Bhutani G, Nasr SH, Said SM, et al. Hematologic characteristics of proliferative glomerulonephritides with nonorganized monoclonal immunoglobulin deposits. Mayo Clin Proc. 2015;90:587–96.CrossRef
7.
go back to reference Nasr SH, Markowitz GS, Stokes MB, et al. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis. Kidney Int. 2004;65:85–96.CrossRef Nasr SH, Markowitz GS, Stokes MB, et al. Proliferative glomerulonephritis with monoclonal IgG deposits: a distinct entity mimicking immune-complex glomerulonephritis. Kidney Int. 2004;65:85–96.CrossRef
8.
go back to reference Guiard E, Karras A, Plaisier E, et al. Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab. Clin J Am Soc Nephrol. 2011;6:1609–16.CrossRef Guiard E, Karras A, Plaisier E, et al. Patterns of noncryoglobulinemic glomerulonephritis with monoclonal Ig deposits: correlation with IgG subclass and response to rituximab. Clin J Am Soc Nephrol. 2011;6:1609–16.CrossRef
9.
go back to reference Sumida K, Ubara Y, Marui Y, et al. Recurrent proliferative glomerulonephritis with monoclonal IgG deposits of IgG2λ subtype in a transplanted kidney: a case report. Am J Kidney. 2013;62:587–90.CrossRef Sumida K, Ubara Y, Marui Y, et al. Recurrent proliferative glomerulonephritis with monoclonal IgG deposits of IgG2λ subtype in a transplanted kidney: a case report. Am J Kidney. 2013;62:587–90.CrossRef
10.
go back to reference Ohashi R, Sakai Y, Otsuka T, et al. Proliferative glomerulonephritis with monoclonal IgG2κ deposit successfully treated with steroids: a case report and review of the literature. CEN Case Rep. 2013;2:197–203.CrossRef Ohashi R, Sakai Y, Otsuka T, et al. Proliferative glomerulonephritis with monoclonal IgG2κ deposit successfully treated with steroids: a case report and review of the literature. CEN Case Rep. 2013;2:197–203.CrossRef
11.
go back to reference Li M, Xu G. An update of proliferative glomerulonephritis with monoclonal immunoglobulin deposits. Clin Kidney J. 2021;15:1041–8.CrossRef Li M, Xu G. An update of proliferative glomerulonephritis with monoclonal immunoglobulin deposits. Clin Kidney J. 2021;15:1041–8.CrossRef
12.
go back to reference Omokawa A, Komatsuda A, Hirokawa M, et al. Membranous nephropathy with monoclonal IgG4 deposits and associated IgG4-related lung disease. Clin Kidney J. 2014;7:475–8.CrossRef Omokawa A, Komatsuda A, Hirokawa M, et al. Membranous nephropathy with monoclonal IgG4 deposits and associated IgG4-related lung disease. Clin Kidney J. 2014;7:475–8.CrossRef
13.
go back to reference Zand L, Rajkumar SV, Leung N, et al. Safety and efficacy of daratumumab in patients with proliferative GN with monoclonal immunoglobulin deposits. J Am Soc Nephrol. 2021;32:1163–73.CrossRef Zand L, Rajkumar SV, Leung N, et al. Safety and efficacy of daratumumab in patients with proliferative GN with monoclonal immunoglobulin deposits. J Am Soc Nephrol. 2021;32:1163–73.CrossRef
Metadata
Title
A rare case of proliferative glomerulonephritis with monoclonal IgG2 kappa deposit: a case report
Authors
Daisuke Ito
Yuriko Shiozaki
Yoshitaka Shimizu
Yumiko Suzuki
Asami Takeda
Taro Misaki
Publication date
01-12-2022
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2022
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/s12882-022-03029-6

Other articles of this Issue 1/2022

BMC Nephrology 1/2022 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.